Applied Biosystems (ABI) reported slight revenue rises in its third quarter performance, but long term, the lab firm acknowledged its instrument arm had been negatively affected by a weakened pharmaceutical environment.
The proposed split of the Celera Group from its parent Applera Corporation to form a separate, publicly-traded company is gathering momentum with a preliminary prospectus now filed with the US Securities and Exchange Commission.
Applied Biosystems has sequenced a human genome for just $60,000 in a project that significantly undercuts the $100,000 milestone achieved by the industry and setting the scene for a price war between DNA sequencing tool specialists.
Applied Biosystems has developed a new chemistry reagent kit for DNA analysis by forensic laboratories of material recovered in sexual assault cases. In these cases speed and accuracy are the watchwords and the new kit will help the analyst to rapidly generate information from any complicated DNA evidence that is...
Applera has announced its intentions to separate its Celera Group from the Applera Corporation, forming a separate, publicly-traded company, subject to approval from the US Securities and Exchange Commission and Applera's board of directors.